Condition: Acute Heart Failure (AHF) · Congestive Heart Failure(CHF) · Sponsor: Consorci Sanitari Integral
Treatment of congestion is one of the main goals in patients hospitalized for acute heart failure. Nevertheless, current evidence shows that decongestion is often not achieved and that residual congestion at discharge is strongly associated with poor outcomes. While this association has been demonstrated, previous studies have primarily focused on single parameters of congestion (physical examination, biomarkers, or imaging features). The aim of the study is to assess residual congestion at discharge using a multiparametric approach and to compare the prognostic value of each evaluation strategy. Additionally, the analysis will be supported by artificial intelligence to develop a multiparametric prognostic algorithm that can provide an improved predictive model compared to standard statistical approaches.
This description comes directly from the study's public registry record.
Giosafat Spitaleri, M.D. · +34 654471303 · gspitaleri@csi.cat
Roman Freixa, M.D., Ph.D. · +34 935 53 12 00 · roman.freixa@csi.cat
Always discuss trial participation with your own doctor first.
| Complex Hospitalari Universitari Moisès Broggi | Sant Joan Despí, Barcelona, Spain | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06993220